Efficacy of continued alendronate for fr
โ
Ann V Schwartz; Douglas C Bauer; Steven R Cummings; Jane A Cauley; Kristine E En
๐
Article
๐
2010
๐
American Society for Bone and Mineral Research
๐
English
โ 102 KB
## Abstract In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. Continuing ALN reduced the risk of clinical but not morphometric vertebral fractu